Determination of the effectiveness of unified group cognitive behaviour therapy for patients with heterogeneous anxiety disorders in Klang Valley, Malaysia
Abstract
The prevalence rate of anxiety disorders both globally and in Malaysia has increased for the past decade. However, many patients with anxiety disorder remain under-treated or untreated. Based on the literature review, the problems were rooted in poor treatment delivery on this disorder (i.e., poor dissemination of treatments to the clinicians and limited availability of treatments for patients). Therefore, current study intended to provide solutions to this problem. There are two phases of study. Phase 1 involved the validation of measures used. While Phase 2 evaluate the effectiveness of Unified Group Cognitive Behaviour Therapy as an adjunct to pharmacological treatment (Treatment-As-Usual) (Group CBT+TAU) for patients with heterogeneous anxiety disorders in Klang Valley, Malaysia. Patients diagnosed with heterogeneous anxiety disorders (N=242) were randomly allocated to receive either Unified GCBT+TAU (n=81), or Group Relaxation Training (GRT)+TAU (n=81), or TAU alone (n=80). The Unified GCBT+TAU and GRT+TAU consisted of eight and seven sessions, respectively. The primary outcome measure was the Beck Anxiety Inventory-Malay. The secondary outcome measures consisted of other symptom measures of anxiety (PAS-Malay and FQ-Malay), catastrophic cognition measures (CCQ-Modified-Malaysia and ACQ-Malaysia), a quality of life measure (WHOQOL-BREF-Malay), and a symptom measure of depression (Beck Depression Inventory-Malay). All the measures were validated in terms of its construct…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 242 participants or records.
Read the paper
Related studies
- Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2)
- In silico and in vitro studies: investigating the chemical composition, DFT, molecular docking, and dynamic simulation of Satureja candidissima (Munby) Briq essential oil as a potential antibacterial agent
- Quercetin combined with ciprofloxacin and gentamicin inhibits biofilm formation and virulence in Staphylococcus aureus
- In silico study of the mechanism of action, pharmacokinetic and toxicological properties of some N-methylanthranilates and their analogs
- Anticonvulsant Effects of Citronellal, Daidzin, and Phytol, Possibly Through GABAA Receptor and Voltage-Gated Sodium Channel Interaction Pathways: In Vivo and In Silico Studies
- 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as D3R-Selective Ligands for 3D-QSAR, Docking and Molecular Dynamics Simulation Studies
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.